Electronic Cigarettes


Are electronic cigarettes "a miracle" as some users claim, or an unproven-and potentially harmful-smoking cessation aid?

The handyman who does repairs on our house says he started smoking in the cradle. He’s tried to quit smoking countless times and hasn’t been successful until recently when he started smoking electronic cigarettes. He says electronic cigarettes are a miracle.

So what exactly are electronic cigarettes (or e-cigarettes) and are they safe and effective? Electronic cigarettes are battery-powered inhalers, which look like cigarettes, that turn tobacco-free, nicotine-filled liquid into a vapor mist. Consequently, using an electronic cigarette is sometimes called “vaping” and people using them are called “vapers” rather than smokers.

Electronic cigarettes were invented in 2003 by a pharmacist in China and introduced in the U.S. in 2006. The U. S. Food and Drug Administration attempted to regulate electronic cigarettes as a smoking cessation device; however, they lost the court battle and now are attempting to regulate them as tobacco products. In a 2010 review of 16 studies by MB Siegel et al., electronic cigarettes were found to have three main ingredients: nicotine (although some do not contain nicotine), propylene glycol, and glycerin. The reviewers couldn’t conclude that electronic cigarettes are absolutely safe and noted that more studies are needed. However, they did note that electronic cigarettes are safer than smoking tobacco.

According to the Centers for Disease Control (CDC), e-cigarette use quadrupled from 2009 to 2010. In a 2010 survey, the CDC found that 1.2% of adults, or 3 million people, reported using electronic cigarettes in the previous month. Since it’s estimated that about 50 million smoke cigarettes in the US, electronic cigarettes may hold promise for smokers who wish to quit. However, despite the claims of many users who view electronic cigarettes as a miracle, many clinicians are not endorsing electronic cigarettes without further study.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Jessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP, in an interview with Oncology Nursing News
Andrea Wagner, M.S.N., RN, OCN, in an interview with Oncology Nursing News discussing her abstract on verbal orders for CRS.
John Rodriguez in an interview with Oncology Nursing News discussing his abstract on reducing nurse burnout
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.